Aurinia Pharmaceuticals (AUPH) Earnings
|
Expand Research on AUPH
| Next EPS Date | 5/2/24 | EPS Growth Rate | +22.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +28.0% | Revenue Growth Rate | +36.8% |
| Average % Move 1-Wk after EPS | -6.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/24  |
Q124 | N/A | -$0.14 | N/A | N/A | $47.07M | = | N/A | N/A | ||
| 2/15/24 | Q423 | -$0.19 | -$0.16 | -$0.03 | $45.1M | $44.2M | = |  | | Details | |
| 11/2/23 | Q323 | -$0.09 | -$0.17 | +$0.08 | $40.8M | $38.44M | = | | | Details | |
| 8/3/23 | Q223 | -$0.08 | -$0.18 | +$0.10 | $41.49M | $37.9M | = | | | Details | |
| 5/4/23 | Q123 | -$0.18 | -$0.25 | +$0.07 | $34.4M | $28.12M | = | | | Details | |
| 2/28/23 | Q422 | -$0.18 | -$0.27 | +$0.09 | $28.4M | $27.42M | = | | | Details | |
| 11/15/22 | Q322 | N/A | -$0.23 | N/A | N/A | $32.42M | = | N/A | N/A | ||
| 8/4/22 | Q222 | -$0.25 | -$0.22 | -$0.03 | $28.2M | $27.04M | = | | | Details |
